跳至主要内容
临床试验/NCT05549869
NCT05549869尚未招募不适用

Assessment of Serum Leptin in Vitiligo Patients

Sohag University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2022年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
400
试验地点
1
主要终点
level of serum leptin

研究概览

简要总结

Evaluation of serum leptin in vitiligo patients and control Assessing its correlation to the body mass index and disease dermographic data .

详细描述

, leptin is supposed to contribute to vitiligo pathogenesis through promoting the release of pro-inflammatory mediators such as tumor necrosis factor α "TNF," IL-2 and IL-6, as well as enhancing cytotoxic T cells "CD8" recruitment and inhibiting the functions of regulatory T cells "Tregs". Leptin can also aid in induction of oxidative stress by activating nicotinamide adenine dinucleotide phosphate (NADPH) oxidase• Venous blood samples will be taken from patients and controls to evaluate serum leptin: Morning samples will be taken after 12-h overnight fast in plain vacutainer tubes and directly centrifuged (1098 g for 15 min).

  • Sera will be then collected in plain, capped, 5 ml centrifuge tubes "Eppendorf" and freezed at -20ᵒC in a well-monitored freezer until the analysis is performed• Serum leptin will be quantitatively assessed in vitro using DRG leptin Sandwich Enzyme Linked Immuno-Sorbent Assay "ELISA".
  • ELISA will be performed according to manufacturer's guidelines where each run included a standard curve.
  • Using the mean absorbance value for each sample, the corresponding concentration from the standard curve will be determined.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with vitiligo who are above the age of 18 years

排除标准

  • Patients with other autoimmune diseases

结局指标

主要结局

level of serum leptin

时间窗: 6 month

Evaluation of serum leptin in vitiligo patients and control Assessing its correlation to the body mass index and disease dermographic data .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doaa Zaghloul Amin

dermatology and andrology resident in luxor international hospital

Sohag University

研究点 (1)

Loading locations...

相似试验